Ian Schofield

Ian Schofield

Ian Schofield has been writing on issues affecting the pharmaceutical and biotech industry since the mid-1980s. He writes for Scrip and Pink Sheet and can be contacted at ian.schofield@informa.com.

Recent posts

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Sponsored · Whitepaper
Doing Business in a World of Uncertainty
A growing nationalist and protectionist mindset around the world is creating a fresh set of challenges for global businesses
IDA Ireland

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!